The systemic load and efficient delivery of active 5-aminosalicylic acid in patients with ulcerative colitis on treatment with olsalazine or mesalazine-Reference-Cited by-同舟云学术

The systemic load and efficient delivery of active 5-aminosalicylic acid in patients with ulcerative colitis on treatment with olsalazine or mesalazine

Published:1999-03 Issue:3 Volume:13 Page:357-361
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

STØA-BIRKETVEDT ,FLORHOLMEN

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.1999.00483.x/fullpdf

Reference16 articles.

1. Sulphasalazine. Pharmacology, clinical use, toxicity, and related new drug development;Peppercorn;Ann Intern Med,1984

2. Disposition of 5-aminosalicylic acid by olsalazine and three preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion;Staerk Laursen;Gut,1990

3. Akute interstitielle nephritis durch 5-aminosalicylsäure?;Ruf-Ballauf;Internist,1989

4. Nephrotic syndrome after treatment with 5-aminosalicylic acid;Novis;Gut,1988

5. Controlled trial of sulphasalazine in the treatment of ulcerative colitis;Dick;Gut,1964

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory bowel disease biomarkers;Medicinal Research Reviews;2022-05-23

2. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis;Cochrane Database of Systematic Reviews;2020-08-28

3. Ulcerative Colitis;Evidence-based Gastroenterology and Hepatology 4e;2019-02-27

4. Current Medical Therapies for Ulcerative Colitis;Pouchitis and Ileal Pouch Disorders;2019

5. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis;Cochrane Database of Systematic Reviews;2016-05-09